Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2698-2703
Published online before print October 16, 2003, doi: 10.1161/01.STR.0000092121.62649.DC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/11/2698    most recent
01.STR.0000092121.62649.DCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trauernicht, A. K.
Right arrow Articles by Mayhan, W. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trauernicht, A. K.
Right arrow Articles by Mayhan, W. G.
Related Collections
Right arrow ACE/Angiotension receptors
Right arrow Type 1 diabetes
Right arrow Brain Circulation and Metabolism
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2003;34:2698.)
© 2003 American Heart Association, Inc.


Original Contributions

Enalapril Prevents Impaired Nitric Oxide Synthase–Dependent Dilatation of Cerebral Arterioles in Diabetic Rats

Anna K. Trauernicht, BSc; Hong Sun, MD, PhD; Kaushik P. Patel, PhD William G. Mayhan, PhD

From the Department of Physiology and Biophysics, University of Nebraska Medical Center, Omaha.

Correspondence to Dr William G. Mayhan, Department of Physiology and Biophysics, 984575 Nebraska Medical Center, Omaha, NE 68198-4575. E-mail wgmayhan{at}unmc.edu

Background and Purpose— Our goal was to identify the effects of chronic treatment with enalapril on cerebrovascular dysfunction and endothelial nitric oxide synthase (eNOS) protein in diabetic rats.

Methods— Rats were assigned to 1 of 4 groups: nondiabetic, diabetic, nondiabetic/enalapril-treated, and diabetic/enalapril-treated groups. Rats assigned to the nondiabetic groups were injected with vehicle (sodium citrate buffer), and rats assigned to the diabetic groups were injected with streptozotocin (50 mg/kg IP). Enalapril (10 mg/kg per day) was administered in the drinking water and coincided with the injection of vehicle or streptozotocin. Two to 3 months later, we examined responses of pial arterioles to nitric oxide synthase (NOS)–dependent agonists (acetylcholine and ADP) and a NOS-independent agonist (nitroglycerin). After these functional studies, we harvested cerebral microvessels for Western blot analysis of eNOS protein.

Results— We found that acetylcholine- and ADP-induced dilatation of pial arterioles was impaired in diabetic compared with nondiabetic rats. In addition, while enalapril did not alter responses in nondiabetic rats, enalapril prevented diabetes-induced impairment of NOS-dependent vasodilatation. Furthermore, eNOS protein was higher in diabetic than in nondiabetic rats, and enalapril did not produce a further increase in eNOS protein in enalapril-treated diabetic rats compared with untreated diabetic rats.

Conclusions— These results suggest that enalapril prevents cerebrovascular dysfunction in diabetic rats. We speculate that the protective role of enalapril may be independent of an alteration in eNOS protein in cerebral microvessels.


Key Words: acetylcholine • adenosine • angiotensin converting enzyme inhibitors • brain • nitric oxide • nitroglycerin • stroke • rats




This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Cerebral Blood Flow Regulation by Nitric Oxide: Recent Advances
Pharmacol. Rev., March 1, 2009; 61(1): 62 - 97.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. Zhang, Y.-G. Bai, L.-J. Lin, J.-X. Bao, Y.-Y. Zhang, H. Tang, J.-H. Cheng, G.-L. Jia, X.-L. Ren, and J. Ma
Blockade of AT1 receptor partially restores vasoreactivity, NOS expression, and superoxide levels in cerebral and carotid arteries of hindlimb unweighting rats
J Appl Physiol, January 1, 2009; 106(1): 251 - 258.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
D. Last, D. C. Alsop, A. M. Abduljalil, R. P. Marquis, C. de Bazelaire, K. Hu, J. Cavallerano, and V. Novak
Global and Regional Effects of Type 2 Diabetes on Brain Tissue Volumes and Cerebral Vasoreactivity
Diabetes Care, May 1, 2007; 30(5): 1193 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda, K. Ayajiki, and T. Okamura
Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation
Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
V. Novak, D. Last, D. C. Alsop, A. M. Abduljalil, K. Hu, L. Lepicovsky, J. Cavallerano, and L. A. Lipsitz
Cerebral Blood Flow Velocity and Periventricular White Matter Hyperintensities in Type 2 Diabetes
Diabetes Care, July 1, 2006; 29(7): 1529 - 1534.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Fujiki, H. Shimokawa, K. Morikawa, H. Kubota, M. Hatanaka, M.A. H. Talukder, T. Matoba, A. Takeshita, and K. Sunagawa
Endothelium-Derived Hydrogen Peroxide Accounts for the Enhancing Effect of an Angiotensin-Converting Enzyme Inhibitor on Endothelium-Derived Hyperpolarizing Factor-Mediated Responses in Mice
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 766 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
W. G. Mayhan, H. Sun, J. F. Mayhan, and K. P. Patel
Influence of exercise on dilatation of the basilar artery during diabetes mellitus
J Appl Physiol, May 1, 2004; 96(5): 1730 - 1737.
[Abstract] [Full Text] [PDF]